Efficacy of metformin treatment in polycystic ovary syndrome
Učinkovitost zdravljenja sindroma policističnih jajčnikov z metforminom
DOI:
https://doi.org/10.18690/actabiomed.87Keywords:
polycystic ovary syndrome, metformin, pharmacogenetics, personalized medicineAbstract
Metformin is an oral antidiabetic drug with potentially beneficial effects in patients with polycystic ovary syndrome (PCOS). Different pharmacological responses to met- formin have been reported in PCOS patients, which may be attributable to various clinical, biochemical, genetic and other factors. Here, we have outlined a short review of the results from current clinical studies on metformin efficacy in PCOS patients. Additionally, preliminary results from a retrospective pharmacogenetic study by our group on a sample of Slovene PCOS patients are presented. Pharmacogenetics is an emerging science that should pro- vide options for individualized medicine, the future of healthcare.
Downloads
Downloads
Published
Issue
Section
License
Copyright (c) 2013 Acta Medico-Biotechnica

This work is licensed under a Creative Commons Attribution 4.0 International License.